Kent Ellington

Kent Ellington, MD, serves as an Investor and Advisor at multiple companies, including Nufabrx and Reselute, while holding the position of Medical Director at OrthoCarolina Foot and Ankle Institute. As Co-Founder and CMO of Pressio, Kent actively contributes to the company's direction. Investment roles extend to organizations such as OmniLife, Sparta Biomedical, Zen Running Club, Marrow Access Technologies, Artelon, and PROOF Alcohol Ice Cream. Kent's extensive educational background includes a Doctor of Medicine from Wake Forest University School of Medicine, a Foot and Ankle Reconstructive Fellowship at Mercy Medical Center, and an Orthopaedic Surgery Residency at Carolinas Medical Center. Additionally, Kent holds two Master's degrees and a Bachelor's degree in Biology from the University of North Carolina at Charlotte.